CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.47% | -51.37% | 11.77% | 44.20% | 105.44% |
| Total Depreciation and Amortization | 3.72% | 2.69% | 1.93% | 0.56% | 0.40% |
| Total Amortization of Deferred Charges | -3.58% | -6.77% | -5.83% | -6.83% | -8.48% |
| Total Other Non-Cash Items | 1,777.62% | 329.36% | 91.97% | -31.55% | -114.59% |
| Change in Net Operating Assets | 71.17% | -90.06% | -312.86% | -61.32% | -0.37% |
| Cash from Operations | 2.23% | -6.85% | -5.57% | 13.31% | 33.20% |
| Capital Expenditure | -51.38% | -34.79% | -6.89% | 11.81% | 31.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 185.00% | -- |
| Cash from Investing | -60.17% | -28.68% | -1.53% | 21.53% | 34.68% |
| Total Debt Issued | -4.04% | -12.46% | -19.45% | -14.23% | 8.53% |
| Total Debt Repaid | 3.37% | 9.66% | 17.06% | 10.35% | -5.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.39% | -0.44% | -0.41% | -0.49% | -0.61% |
| Other Financing Activities | 32.87% | 41.11% | 35.56% | -28.93% | -2,725.56% |
| Cash from Financing | 10.05% | 5.78% | 7.81% | -22.28% | -36.74% |
| Foreign Exchange rate Adjustments | 189.86% | -67.29% | 183.33% | -301.45% | -678.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9,935.58% | -94.20% | 396.18% | -77.86% | 103.51% |